Skip to content
Trial Eligibility
Menu

Auricular Neuromodulation in Veterans With Fibromyalgia

NCT06415591

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

PENFS (percutaneous electrical nerve field stimulation) is an FDA-cleared acupuncture-like therapy applied to the external ear targeting several cranial nerve branches including the auricular branch of the vagus nerve to improve pain, physical function, and reduce symptoms of opioid withdrawal. PENFS has been previously shown to provide improvements in fibromyalgia, a difficult to treat chronic pain syndrome, which correlate with changes observed using a special kind of MRI called resting state functional connectivity MRI (rs-fcMRI) that evaluates brain activity at rest.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Fibromyalgia

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
VA Office of Research and Development
Last updated on ClinicalTrials.gov
May 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Georgia · 1

  • Atlanta VA Medical and Rehab Center, Decatur, GA · Decatur, GA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.